Login / Signup

SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells.

Samuel A MyersSailaja PeddadaNilanjana ChatterjeeTara FriedrichKiichrio TomodaGregor KringsSean ThomasJason MaynardMichael BroekerMatthew ThomsonKatherine PollardShinya YamanakaAlma L BurlingameBarbara Panning
Published in: eLife (2016)
The transcription factor SOX2 is central in establishing and maintaining pluripotency. The processes that modulate SOX2 activity to promote pluripotency are not well understood. Here, we show SOX2 is O-GlcNAc modified in its transactivation domain during reprogramming and in mouse embryonic stem cells (mESCs). Upon induction of differentiation SOX2 O-GlcNAcylation at serine 248 is decreased. Replacing wild type with an O-GlcNAc-deficient SOX2 (S248A) increases reprogramming efficiency. ESCs with O-GlcNAc-deficient SOX2 exhibit alterations in gene expression. This change correlates with altered protein-protein interactions and genomic occupancy of the O-GlcNAc-deficient SOX2 compared to wild type. In addition, SOX2 O-GlcNAcylation impairs the SOX2-PARP1 interaction, which has been shown to regulate ESC self-renewal. These findings show that SOX2 activity is modulated by O-GlcNAc, and provide a novel regulatory mechanism for this crucial pluripotency transcription factor.
Keyphrases
  • transcription factor
  • stem cells
  • gene expression
  • wild type
  • dna binding
  • embryonic stem cells
  • dna methylation
  • signaling pathway